Media & Resources

Filter by

  • Type

  • Health area

  • Location

  • Topic

  • Year

  • Journal

  • Publication

  • Fact sheet & publication type

  • Clear all

Features

IAVI’s Human Immunology Laboratory relocates samples to Africa, fulfilling capacity strengthening goal

May 7, 2024

Lab to close June 30, 2024

Read more

Features

TB vaccine workshop report published in Frontiers in Tuberculosis

May 2, 2024

Workshop examined high-burden country data needs for future TB vaccine introduction

Read more

Features

World Vaccine Congress highlights IAVI’s R&D from end to end

March 29, 2024

IAVI leaders to share updates on our emerging infectious disease R&D portfolio and our work to make much-needed vaccines and antibodies globally accessible

Read more

Features

IAVI and partners kick-start CELEBRATE study to explore acceptability and feasibility of bnAbs for infant HIV prevention 

March 5, 2024

Study focuses on socio-behavioral research to enhance understanding of preferences and factors influencing bnAb adoption for infant indication.

Read more

Features

IAVI statement on mRNA HIV vaccine candidate trials

March 2, 2024

Response to Science news article

Read more

Features

Championing domestic financing to promote a vibrant vaccine research and development enterprise in Africa

February 7, 2024

Advocating for financing for vaccine and health research, development, and innovation for Africa by Africa.

Read more

Features

Penta – Child Health Research announces new partnership with IAVI and Achilles Vaccines

February 1, 2024

Partnership will advance monoclonal antibody development.

Read more

Features

IAVI recommends new business models for increasing access to monoclonal antibodies

January 4, 2024

New approaches could help advance access to a promising medical innovation, consortium finds.

Read more